US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.16 against a street estimate of 0.16 — a beat of 0.0%.
Analysts rate Bausch + Lomb Corp a buy (7 buy, 7 hold, 1 sell out of 15) with an average price target of $19.39.
CONFIDENT BLCO delivered 8% constant currency revenue growth and 28% EBITDA growth in Q2, raising full-year guidance. Surgical surged 16%, Pharma 14%, Vision Care 4%. Net leverage improved to 4.7x. Strong cash conversion and pipeline momentum underscore confidence in 2028 targets. Q2 2026 Contact lens portfolio showed balanced global growth. Canada +11%, Asia Pacific +3%. Consumer pressure tracked gas prices. Analysts pressed on three-year plan credibility (Saunders: delivered 4 quarters, broad metrics improving), surgical post-recall momentum (momentum real, not catch-up), and H2 comp toughness (seasonality, fundamental momentum offset comps). Management emphasized say-do consistency and structural durability. 2026-07-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| ICAHN CARL C | 0.98% |
| Oaktree Capital Management LLC | 0.96% |
| Deutsche Bank AG | 0.96% |
| D. E. Shaw & Co LP | 0.93% |
| Davidson Kempner Capital Management LP | 0.88% |
| Goldentree Asset Management LP | 0.74% |
| T. Rowe Price Associates, Inc. | 0.61% |
| Caspian Capital Partners, L.P. | 0.56% |
| Document | Date |
|---|---|
| Board / officer change · Q4 2026 HEADLINE NUMBERS • Bausch + Lomb expects to raise its full-year 2026 guidance for adjusted EBITDA excluding Acquired IPR&D, a non-GAAP measure; the f | 2026-10-13 |
| Material agreement · Q3 2026 BAUSCH + LOMB CORPORATION - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Bausch + Lomb Corporation (ticker: BLCO) is a Canadian-incorporated com | 2026-08-06 |
| Quarterly report · Q2 2026 BAUSCH + LOMB CORPORATION - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Reporting Period: Quarter ended June 30, 2026 • Company Incorporation: Canada • | 2026-07-29 |
| Results announced · Q3 2026 BAUSCH + LOMB Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 revenue: $1.394 billion (up 9% reported, 8% constant currency vs. Q2 2025) • GAAP | 2026-07-29 |
| Shareholder vote results · Q2 2026 BAUSCH + LOMB CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held May 20, 2026 • Total votes cast for director election | 2026-05-20 |
| Quarterly report · Q1 2026 BAUSCH + LOMB CORPORATION – FORM 10-Q SUMMARY For Quarter Ended March 31, 2026 --- HEADLINE NUMBERS • Company: Bausch + Lomb Corporation, headquart | 2026-04-29 |
| Results announced · Q2 2026 BAUSCH + LOMB Q1 2026 RESULTS SUMMARY HEADLINE NUMBERS • Total revenue: $1.244 billion for Q1 2026 vs. $1.137 billion in Q1 2025 • Revenue growth: 9 | 2026-04-29 |
| Proxy statement · Q2 2026 BAUSCH + LOMB CORPORATION – 2026 PROXY STATEMENT SUMMARY CEO TOTAL COMPENSATION • CEO Brenton L. Saunders' exact 2025 compensation figure is not sta | 2026-04-10 |
Readable in the app.
| Announcement | Date |
|---|---|
| Company expects to raise full-year 2026 adjusted EBITDA guidance Bausch + Lomb announced that CEO Brenton Saunders is leaving and that Mr. Appio will serve as interim CEO. The company also said it expects to raise its full-year 2026 guidance for adjusted | 2026-10-13 |
| Raises full-year 2026 revenue and adjusted EBITDA guidance Bausch + Lomb reported strong Q2 2026 results with revenue of $1.394 billion, up 9% year-over-year (8% on constant currency basis). The company raised its full-year 2026 guidance for both re | 2026-07-29 |
| Raises full-year 2026 revenue and adjusted EBITDA guidance based on strong Q1 Bausch + Lomb reported strong Q1 2026 results with revenue of $1.244 billion, up 9% year-over-year (6% excluding favorable currency effects). The company raised full-year 2026 guidance based | 2026-04-29 |
| Q4 and full-year 2025 results announced; 2026 guidance provided Bausch + Lomb reported strong fourth-quarter and full-year 2025 results with solid revenue growth and improved profitability. The company generated $1.405 billion in Q4 revenue (10% growth r | 2026-02-18 |
| Three-year financial targets and fiscal year 2025 guidance reaffirmed at Investor Day Bausch + Lomb held an Investor Day on November 13, 2025, where management announced three-year financial targets, discussed pipeline products in development, and reaffirmed its full-year 202 | 2025-11-13 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bausch + Lomb Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.